LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Structural peculiarities and anticancer activities of two organotin compounds

Photo by trnavskauni from unsplash

Abstract Two new organotin compounds, triphenyl-4,6-diamine-pyrimidine-2-thione-tin(IV) (1) and triphenyl-imidazoline-2-thione-chloro-tin(IV) (2), have been synthesized, spectroscopically and structurally characterized, and their cytotoxic activities have been tested against certain cancer cell lines. Atoms-In-Molecules… Click to show full abstract

Abstract Two new organotin compounds, triphenyl-4,6-diamine-pyrimidine-2-thione-tin(IV) (1) and triphenyl-imidazoline-2-thione-chloro-tin(IV) (2), have been synthesized, spectroscopically and structurally characterized, and their cytotoxic activities have been tested against certain cancer cell lines. Atoms-In-Molecules approach has been applied for the description of the coordination geometry. Both complexes are active against chemotherapy-resistant SK-LMS-1 Leiomyiosarcoma cells (IC50 of 0.1 μM), and this activity is 3–4 times larger than against normal human CCD39Lu fibroblasts. The biological activity results are compared with those determined for other active organotin compounds which have Sn-S bond, and structure-activity relationships including geometry, intermolecular interactions, Hirshfeld surface parameters, etc., are discussed. Besides the anticancer activity, 2 is also unique from structural point of view as the first structure of a triphenyltin complex with Sn coordinated by both sulfur and halide.

Keywords: anticancer activities; structural peculiarities; organotin compounds; geometry; activity; peculiarities anticancer

Journal Title: Journal of Coordination Chemistry
Year Published: 2017

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.